News
FNP-223, previously known as ASN90, is a reversible and substrate-competitive O-GlcNAcase enzyme inhibitor. The oral investigational drug is expected to rapidly increase O-GlcNAcylated tau proteins, ...
“When she would fall in public, people just assumed she was drunk,” said Glenn. “One time she fell backwards on the steps and ...
Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...
5h
The Scarborough News on MSNScarborough man raises over £1600 for charity by walking the Cinder Track
John Maskill, 89, decided to walk the Cinder Track after losing his wife to Progressive Supranuclear Palsy (PSP) in March.
So, let’s talk about faith. I’m no rabbi or scholar, and I’m not trying to write a religious work. But putting my thoughts ...
In a year-long phase II trial, Ambroxol, a widely used cough medicine in Europe, showed target engagement in patients with ...
Linda Ronstadt is 79 years old today. The queen of country rock influenced generations of musicians and helped launch the Eagles.
When progressive supranuclear palsy (PSP), a rare neurodegenerative disorder, started affecting his movement, his wife and ...
Progressive supranuclear palsy (PSP) affects persons in their late 60s to 70s, because of the shrinkage of the upper ...
Amylyx is a high-risk biotech targeting rare diseases with strong cash reserves. Key trials soon may drive a 40% stock upside ...
The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. Drug ...
Secondary progressive MS causes more severe symptoms to develop over time. Connecting with patient organizations and support groups can be helpful.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results